Defining disease activity states and clinically meaningful improvement in primary Sjögren's syndrome with EULAR primary Sjögren's syndrome disease activity (ESSDAI) and patient-reported indexes (ESSPRI)

Raphaèle Seror, Hendrika Bootsma, Alain Saraux, Simon J. Bowman, Elke Theander, Johan G. Brun, Gabriel Baron, Véronique Le Guern, Valérie Devauchelle-Pensec, Manel Ramos-Casals, Valeria Valim, Thomas Dörner, Athanasios Tzioufas, Jacques Eric Gottenberg, Roser Solans Laqué, Thomas Mandl, Eric Hachulla, Kathy L. Sivils, Wan Fai Ng, Anne Laure FauchaisStefano Bombardieri, Roberta Priori, Elena Bartoloni, Vincent Goeb, Sonja Praprotnik, Takayuki Sumida, Sumusu Nishiyama, Roberto Caporali, Aike A. Kruize, Cristina Vollenweider, Philippe Ravaud, Petra Meiners, Pilar Brito-Zerón, Claudio Vitali, Xavier Mariette, Roberto Gerli, Cees Kallenberg, Salvatore De Vita, Frederic Demoulins, Carlomaurizio Montecucco, Matija Tomsic, Hal Scofield, Guido Valesini

Research output: Contribution to journalArticle

85 Citations (Scopus)

Abstract

Objectives To define disease activity levels, minimal clinically important improvement (MCII) and patientacceptable symptom state (PASS) with the primary Sjögren's syndrome (SS) disease activity indexes: European League Against Rheumatism (EULAR) SS disease activity index (ESSDAI) and EULAR SS patientreported index (ESSPRI). Methods For 790 patients from two large prospective cohorts, ESSDAI, physician evaluation of disease activity, ESSPRI and patients' satisfaction with their current health status were recorded. Receiver operating characteristic curve analyses and anchoring methods were used to estimate disease activity levels of ESSDAI and the PASS of ESSPRI. At follow-up visit, patients and physicians assessed, respectively, whether symptoms and disease activity have improved or not. An anchoring method based on this evaluation was used to estimate MCII of ESSDAI and ESSPRI. Results Low-activity (ESSDAI

Original languageEnglish
Pages (from-to)382-389
Number of pages8
JournalAnnals of the Rheumatic Diseases
Volume75
Issue number2
DOIs
Publication statusPublished - Feb 1 2016

Fingerprint

Rheumatic Diseases
Physicians
Patient Satisfaction
ROC Curve
Health Status
Health

ASJC Scopus subject areas

  • Rheumatology
  • Immunology
  • Biochemistry, Genetics and Molecular Biology(all)
  • Immunology and Allergy

Cite this

Defining disease activity states and clinically meaningful improvement in primary Sjögren's syndrome with EULAR primary Sjögren's syndrome disease activity (ESSDAI) and patient-reported indexes (ESSPRI). / Seror, Raphaèle; Bootsma, Hendrika; Saraux, Alain; Bowman, Simon J.; Theander, Elke; Brun, Johan G.; Baron, Gabriel; Le Guern, Véronique; Devauchelle-Pensec, Valérie; Ramos-Casals, Manel; Valim, Valeria; Dörner, Thomas; Tzioufas, Athanasios; Gottenberg, Jacques Eric; Laqué, Roser Solans; Mandl, Thomas; Hachulla, Eric; Sivils, Kathy L.; Ng, Wan Fai; Fauchais, Anne Laure; Bombardieri, Stefano; Priori, Roberta; Bartoloni, Elena; Goeb, Vincent; Praprotnik, Sonja; Sumida, Takayuki; Nishiyama, Sumusu; Caporali, Roberto; Kruize, Aike A.; Vollenweider, Cristina; Ravaud, Philippe; Meiners, Petra; Brito-Zerón, Pilar; Vitali, Claudio; Mariette, Xavier; Gerli, Roberto; Kallenberg, Cees; De Vita, Salvatore; Demoulins, Frederic; Montecucco, Carlomaurizio; Tomsic, Matija; Scofield, Hal; Valesini, Guido.

In: Annals of the Rheumatic Diseases, Vol. 75, No. 2, 01.02.2016, p. 382-389.

Research output: Contribution to journalArticle

Seror, R, Bootsma, H, Saraux, A, Bowman, SJ, Theander, E, Brun, JG, Baron, G, Le Guern, V, Devauchelle-Pensec, V, Ramos-Casals, M, Valim, V, Dörner, T, Tzioufas, A, Gottenberg, JE, Laqué, RS, Mandl, T, Hachulla, E, Sivils, KL, Ng, WF, Fauchais, AL, Bombardieri, S, Priori, R, Bartoloni, E, Goeb, V, Praprotnik, S, Sumida, T, Nishiyama, S, Caporali, R, Kruize, AA, Vollenweider, C, Ravaud, P, Meiners, P, Brito-Zerón, P, Vitali, C, Mariette, X, Gerli, R, Kallenberg, C, De Vita, S, Demoulins, F, Montecucco, C, Tomsic, M, Scofield, H & Valesini, G 2016, 'Defining disease activity states and clinically meaningful improvement in primary Sjögren's syndrome with EULAR primary Sjögren's syndrome disease activity (ESSDAI) and patient-reported indexes (ESSPRI)', Annals of the Rheumatic Diseases, vol. 75, no. 2, pp. 382-389. https://doi.org/10.1136/annrheumdis-2014-206008
Seror, Raphaèle ; Bootsma, Hendrika ; Saraux, Alain ; Bowman, Simon J. ; Theander, Elke ; Brun, Johan G. ; Baron, Gabriel ; Le Guern, Véronique ; Devauchelle-Pensec, Valérie ; Ramos-Casals, Manel ; Valim, Valeria ; Dörner, Thomas ; Tzioufas, Athanasios ; Gottenberg, Jacques Eric ; Laqué, Roser Solans ; Mandl, Thomas ; Hachulla, Eric ; Sivils, Kathy L. ; Ng, Wan Fai ; Fauchais, Anne Laure ; Bombardieri, Stefano ; Priori, Roberta ; Bartoloni, Elena ; Goeb, Vincent ; Praprotnik, Sonja ; Sumida, Takayuki ; Nishiyama, Sumusu ; Caporali, Roberto ; Kruize, Aike A. ; Vollenweider, Cristina ; Ravaud, Philippe ; Meiners, Petra ; Brito-Zerón, Pilar ; Vitali, Claudio ; Mariette, Xavier ; Gerli, Roberto ; Kallenberg, Cees ; De Vita, Salvatore ; Demoulins, Frederic ; Montecucco, Carlomaurizio ; Tomsic, Matija ; Scofield, Hal ; Valesini, Guido. / Defining disease activity states and clinically meaningful improvement in primary Sjögren's syndrome with EULAR primary Sjögren's syndrome disease activity (ESSDAI) and patient-reported indexes (ESSPRI). In: Annals of the Rheumatic Diseases. 2016 ; Vol. 75, No. 2. pp. 382-389.
@article{c73a427478c248e980f337f07980f19e,
title = "Defining disease activity states and clinically meaningful improvement in primary Sj{\"o}gren's syndrome with EULAR primary Sj{\"o}gren's syndrome disease activity (ESSDAI) and patient-reported indexes (ESSPRI)",
abstract = "Objectives To define disease activity levels, minimal clinically important improvement (MCII) and patientacceptable symptom state (PASS) with the primary Sj{\"o}gren's syndrome (SS) disease activity indexes: European League Against Rheumatism (EULAR) SS disease activity index (ESSDAI) and EULAR SS patientreported index (ESSPRI). Methods For 790 patients from two large prospective cohorts, ESSDAI, physician evaluation of disease activity, ESSPRI and patients' satisfaction with their current health status were recorded. Receiver operating characteristic curve analyses and anchoring methods were used to estimate disease activity levels of ESSDAI and the PASS of ESSPRI. At follow-up visit, patients and physicians assessed, respectively, whether symptoms and disease activity have improved or not. An anchoring method based on this evaluation was used to estimate MCII of ESSDAI and ESSPRI. Results Low-activity (ESSDAI",
author = "Rapha{\`e}le Seror and Hendrika Bootsma and Alain Saraux and Bowman, {Simon J.} and Elke Theander and Brun, {Johan G.} and Gabriel Baron and {Le Guern}, V{\'e}ronique and Val{\'e}rie Devauchelle-Pensec and Manel Ramos-Casals and Valeria Valim and Thomas D{\"o}rner and Athanasios Tzioufas and Gottenberg, {Jacques Eric} and Laqu{\'e}, {Roser Solans} and Thomas Mandl and Eric Hachulla and Sivils, {Kathy L.} and Ng, {Wan Fai} and Fauchais, {Anne Laure} and Stefano Bombardieri and Roberta Priori and Elena Bartoloni and Vincent Goeb and Sonja Praprotnik and Takayuki Sumida and Sumusu Nishiyama and Roberto Caporali and Kruize, {Aike A.} and Cristina Vollenweider and Philippe Ravaud and Petra Meiners and Pilar Brito-Zer{\'o}n and Claudio Vitali and Xavier Mariette and Roberto Gerli and Cees Kallenberg and {De Vita}, Salvatore and Frederic Demoulins and Carlomaurizio Montecucco and Matija Tomsic and Hal Scofield and Guido Valesini",
year = "2016",
month = "2",
day = "1",
doi = "10.1136/annrheumdis-2014-206008",
language = "English",
volume = "75",
pages = "382--389",
journal = "Annals of the Rheumatic Diseases",
issn = "0003-4967",
publisher = "BMJ Publishing Group",
number = "2",

}

TY - JOUR

T1 - Defining disease activity states and clinically meaningful improvement in primary Sjögren's syndrome with EULAR primary Sjögren's syndrome disease activity (ESSDAI) and patient-reported indexes (ESSPRI)

AU - Seror, Raphaèle

AU - Bootsma, Hendrika

AU - Saraux, Alain

AU - Bowman, Simon J.

AU - Theander, Elke

AU - Brun, Johan G.

AU - Baron, Gabriel

AU - Le Guern, Véronique

AU - Devauchelle-Pensec, Valérie

AU - Ramos-Casals, Manel

AU - Valim, Valeria

AU - Dörner, Thomas

AU - Tzioufas, Athanasios

AU - Gottenberg, Jacques Eric

AU - Laqué, Roser Solans

AU - Mandl, Thomas

AU - Hachulla, Eric

AU - Sivils, Kathy L.

AU - Ng, Wan Fai

AU - Fauchais, Anne Laure

AU - Bombardieri, Stefano

AU - Priori, Roberta

AU - Bartoloni, Elena

AU - Goeb, Vincent

AU - Praprotnik, Sonja

AU - Sumida, Takayuki

AU - Nishiyama, Sumusu

AU - Caporali, Roberto

AU - Kruize, Aike A.

AU - Vollenweider, Cristina

AU - Ravaud, Philippe

AU - Meiners, Petra

AU - Brito-Zerón, Pilar

AU - Vitali, Claudio

AU - Mariette, Xavier

AU - Gerli, Roberto

AU - Kallenberg, Cees

AU - De Vita, Salvatore

AU - Demoulins, Frederic

AU - Montecucco, Carlomaurizio

AU - Tomsic, Matija

AU - Scofield, Hal

AU - Valesini, Guido

PY - 2016/2/1

Y1 - 2016/2/1

N2 - Objectives To define disease activity levels, minimal clinically important improvement (MCII) and patientacceptable symptom state (PASS) with the primary Sjögren's syndrome (SS) disease activity indexes: European League Against Rheumatism (EULAR) SS disease activity index (ESSDAI) and EULAR SS patientreported index (ESSPRI). Methods For 790 patients from two large prospective cohorts, ESSDAI, physician evaluation of disease activity, ESSPRI and patients' satisfaction with their current health status were recorded. Receiver operating characteristic curve analyses and anchoring methods were used to estimate disease activity levels of ESSDAI and the PASS of ESSPRI. At follow-up visit, patients and physicians assessed, respectively, whether symptoms and disease activity have improved or not. An anchoring method based on this evaluation was used to estimate MCII of ESSDAI and ESSPRI. Results Low-activity (ESSDAI

AB - Objectives To define disease activity levels, minimal clinically important improvement (MCII) and patientacceptable symptom state (PASS) with the primary Sjögren's syndrome (SS) disease activity indexes: European League Against Rheumatism (EULAR) SS disease activity index (ESSDAI) and EULAR SS patientreported index (ESSPRI). Methods For 790 patients from two large prospective cohorts, ESSDAI, physician evaluation of disease activity, ESSPRI and patients' satisfaction with their current health status were recorded. Receiver operating characteristic curve analyses and anchoring methods were used to estimate disease activity levels of ESSDAI and the PASS of ESSPRI. At follow-up visit, patients and physicians assessed, respectively, whether symptoms and disease activity have improved or not. An anchoring method based on this evaluation was used to estimate MCII of ESSDAI and ESSPRI. Results Low-activity (ESSDAI

UR - http://www.scopus.com/inward/record.url?scp=84954398507&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84954398507&partnerID=8YFLogxK

U2 - 10.1136/annrheumdis-2014-206008

DO - 10.1136/annrheumdis-2014-206008

M3 - Article

AN - SCOPUS:84954398507

VL - 75

SP - 382

EP - 389

JO - Annals of the Rheumatic Diseases

JF - Annals of the Rheumatic Diseases

SN - 0003-4967

IS - 2

ER -